Clinical Trials Browser

Interventional × Hodgkin Disease × atezolizumab × Clear all

Hodgkin Disease, Recurrence

NCT03544723 2020-06-09

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

BreastDermatologicGastrointestinalGenitourinaryGynecologicLymphoidThoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Hodgkin Disease, Liver Neoplasms, Lymphoma, Melanoma, Stomach Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT03120676 2019-11-14

Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma

Phase 2 Terminated

3 enrolled 3 charts

Lymphoid

Hodgkin Disease, Recurrence

Clinical Trials

FIL_A-BEGEV

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma